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Abstract 
Objective: To assess the association of anxiety following myocardial infarction (MI) 
with cardiac prognosis. Methods: A meta-analysis of references derived from 
MEDLINE, EMBASE and PSYCINFO (1975- March 2009) was performed without 
language restrictions. Endpoint was cardiac outcome defined as all-cause mortality, 
cardiac mortality and cardiac events. The authors selected prospective studies with at 
least 6 months follow-up and anxiety had to be assessed within 3 months after MI 
with reliable and valid instruments. Results: Twelve papers met selection criteria. 
These studies described follow-up (on average 2.6 years) of 5750 MI patients. 
Anxious patients were at risk of adverse events (odds ratio (OR) fixed: 1.36; 95% 
confidence interval (CI): 1.18-1.56; p<.001). Anxiety was also specifically associated 
with all-cause mortality (OR fixed: 1.47; 95% CI: 1.02-2.13; p=.04), cardiac mortality 
(OR fixed: 1.23; 95% CI: 1.03-1.47; p=.02) and new cardiac events (OR fixed: 1.71; 
95% CI: 1.31-2.23; p<.001).  
Conclusions: Post-MI anxiety is associated with a 36% increased risk of adverse 
cardiac outcomes in bivariate analyses. Since the existing literature is quite small and 
contains several limitations, more research is needed to the association of anxiety and 
prognosis in MI patients and to assess the extent to which this association is 
independent of clinical variables, such as disease severity, and other psychological 
variables, especially depression.  
 
Key words: Anxiety, myocardial infarction, meta-analysis, prognosis, mortality. 
 
BMI=body mass index; CABG=coronary artery bypass graft; CHD=coronary heart 
disease; CI=confidence interval; CBAHF=Cognitive Behavioral Assessment Hospital 
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Form; ENRICHD=Enhancing Recovery in Coronary Heart Disease Patients; 
FEM=fixed effects model; GAD=generalized anxiety disorder; HADS=Hospital 
Anxiety and Depression Scale; HR=Hazard ratio; LVEF=left ventricular ejection 
fraction; MI=myocardial infarction; MIND-IT=Myocardial Infarction and Depression 
Intervention Trial; NA=not available; OR=odds ratio; REM=random effects model; 
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Introduction 
Cardiovascular disease, and in particular acute myocardial infarction (MI), is one of 
the leading causes of morbidity and mortality in industrialized countries [1,2]. Several 
meta-analyses indicate depression as a risk factor for the development of coronary 
heart disease (CHD) in the general population [3,4] and as a prognostic risk factor in 
post-MI patients [5]. In contrast, anxiety is a negative emotion on which much less 
research has focused. Although anxiety is often comorbid with depression, it is a 
distinct emotion [6]. Studies in healthy populations have demonstrated that anxiety is 
significantly related to the development of CHD [7,8]. In addition, anxiety is very 
common in MI patients, with an in-hospital incidence of 30-40% [9-11]. Anxiety has 
been found to be predictive of disability, increased physical symptoms, worse 
functional status and worse quality of life in CHD patients [12-14].  
The role of anxiety regarding cardiac prognosis is unclear. Several studies in CHD 
patients have shown that anxiety is related to adverse cardiac outcomes, defined as 
fatal and nonfatal cardiac events and in-hospital ischemic and arrhythmic 
complications [15-19]. However, others did not find a relationship between anxiety 
and cardiac and all-cause mortality [20-23], or even found a protective impact of 
anxiety on all-cause death, recurrent MI and revascularization [24,25]. Moreover, one 
study showed that when entering both anxiety and depression in a single prediction 
model, the effects of depression were explained away by those of anxiety [26], but 
this finding was not confirmed by other studies [27]. 
 
Therefore, the present paper focuses on anxiety as a predictor of medical prognosis 
after MI. To our knowledge, this is the first meta-analysis on the prognostic 
association of anxiety in heart disease patients with medical outcome. Objective of 
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this study was to investigate the association of anxiety after MI with all-cause death, 





To identify all studies that were available by March 2009, comparing cardiac 
prognosis of anxious and non-anxious MI patients. Systematic identification, 
appraisal, synthesis, statistical aggregation and reporting of results   resembled known 
guidelines [28,29].  
 
Literature search 
Regarding literature search, the electronic databases MEDLINE, EMBASE and 
PSYCINFO (1975- March 2009) were searched using the following terms: 
“myocardial infarction” and “anxiety”, without language restrictions. We included 
both published and unpublished data (e.g. doctoral dissertations). In addition, 
reference lists of included studies and review articles were hand searched to identify 
additional studies meeting selection criteria. 
 
Selection 
In the resulting pool of studies, two independent raters (A.R. and E.M.) identified 
studies that met the following inclusion criteria: 
  
1. Studies should contain patients who were hospitalized for acute MI.  
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2. Anxiety (non-phobic) had to be measured within 3 months of hospitalization for 
acute MI using reliable and validated instruments to assess anxiety (either self-report 
or interview-based). 
3. Studies had to be prospective in nature with at least 6 months follow-up and 
endpoints had to contain: all cause mortality, cardiac mortality, and/or cardiac events 
(e.g. hospitalization for unstable angina pectoris (UA), revascularization) in 
combination with mortality and/or recurrent MI, using a reliable and valid assessment 
strategy. 
4. Studies had to present original data (e.g. reviews and editorials were excluded). 
During the selection procedure, in case of disagreement between the two independent 
raters, the four investigators discussed the difference of opinion until consensus was 
reached. Regarding multiple reports on the same dataset, only one paper was included 
based on endpoint and follow-up period, preferring hard medical endpoints (e.g. 
mortality) and longer follow-up periods. Two studies presented an analysis on a 
combined sample of MI and UA patients and we also included these studies [18,30]. 
Data derived from patients randomized to placebo from a blind placebo-controlled 
medication trial in which anxiety was measured as part of an ancillary study, was 
included [31]. If necessary, the coordinators of the eligible studies were asked for 
details.   
The following aspects of methodological quality were evaluated: sample size, study 
population (e.g. did the researchers include specific in-/exclusion criteria such as 
gender or disease severity), percentage lost to follow-up, follow-up duration and 
multivariable adjustment. We did not weigh the contribution of each study to the 
meta-analysis on the basis of quality scoring for there are no validated measures of 
quality and the use of subjective rating scales may lead to bias [32]. 
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Endpoint 
The endpoint was all-cause mortality, cardiac mortality and/or cardiac events.  
 
Quantitative data synthesis 
Data from all studies were pooled using the program Comprehensive Meta-Analysis 
version 2. To pool data across studies, we converted the time-related data into simple 
2 x 2 tables. Thus, for all studies, irrespective of the presented effect measure (i.e. 
odds ratio (OR) or hazard ratio (HR)), data were converted into (unadjusted) 
dichotomous outcomes. Subsequently, ORs and 95% confidence intervals (CI) were 
calculated. The fixed and the random effect method (REM) were used to generate 
summary estimates of ORs. The appropriateness to combine results was tested with 
the I² test, which shows the proportion of total variance explained by heterogeneity. If 
I² was found to be less than 25% it was considered as low [33] and variation in the 
results of different studies thought to be due tot chance alone [29]. In that case we 
based our main conclusions on the OR reported by the fixed effect method (FEM). 
We provided both estimates in the results section for the purpose of completeness.  
In two studies [11,27], more than one measure of anxiety was included. In these cases 
the most representative measure of anxiety (i.e. State Trait Anxiety Inventory 
(STAI)), as compared to the anxiety measures in other included studies, was chosen. 
In three studies [11,31,34], anxiety symptoms were presented as a continuous 
variable. In these cases, the number of patients above and below the established cut-
off point of the anxiety scale was estimated using the reported mean anxiety score and 
standard deviation based on the assumption of normal distribution. For studies using 
the STAI [11,31] a cut-off score ≥ 44 was chosen. For the study of Mayou et al. [23], 
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the OR was calculated based on earlier information given by the author to one of the 
authors of the current study (P.d.J.). In two studies [9,27], the number of anxious and 
non-anxious patients in the event versus non-event group was calculated from the 
given OR or HR. 
The study of Pedersen et al. [35] was excluded based on the questionnaire used, 
namely the Trauma Symptom Checklist, which intends to measure traumas. 
Moreover, one study that measured anxiety before the MI was excluded [36].  
If study outcomes were heterogeneous based on the I
2
 test, the possible effects of 
follow-up duration, year of data collection, study population (MI versus MI and UA 
patients) and trait versus state anxiety would be studied. Differences in ORs between 
specified subgroups were assessed by comparing the pooled ORs using chi-squared 
analysis, comparing logarithms of the ORs. In order to evaluate the presence of 
publication bias, a funnel plot was constructed by plotting the effect measure against 
the inverse of its standard error.  
 
Additional information by personal communication 
Authors of four included studies were contacted for further information on study 
characteristics. Michael et al. confirmed that the reported endpoint consisted of 
ischemic cardiac events as verified by a cardiologist [30]. The study of Pfiffner and 
Hoffmann [37] was excluded because reported survival data was imprecise and we 
were not able to reproduce the reported OR. The article of Legault et al. [38] was 
excluded because reported data was limited and we could not compute an OR. We 
used the age- and gender-adjusted HR given in the paper of Frasure-Smith and 
Lespérance [27] to estimate the numbers of anxious and non-anxious patients in the 
event and non-event group.  
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Results 
A flow diagram of the literature search is shown in Figure 1. The agreement rates 
(Cohen’s kappa) for the 2 steps in the selection procedure were 0.72 and 0.93 
respectively, indicating good to very good consistency of judgment by raters [39]. 
Twelve studies met selection criteria and study characteristics are shown in table 1. 
Fifteen analyses reported on the pre-specified endpoint (4 on all-cause mortality, 4 on 
cardiac mortality and 7 on cardiac events). These studies described follow-up (on 
average 2.6 years) of 5750 MI patients. The mean age at time of the index MI ranged 
from 54 to 63 years and 82.5% of patients was male. The proportion of MI patients 
with anxiety symptoms at baseline ranged from 13.4% to 59.5%. Five analyses (2 on 
cardiac mortality and 3 on cardiac events) reported a significant association between 
anxiety and prognosis in bivariate analysis. In 2 studies the association was no longer 
significant when controlling for demographic (e.g. age, gender) and clinical (e.g. 
disease severity) variables. Three analyses, 2 reporting on the association between 
anxiety and cardiac mortality or recurrent MI and one reporting on cardiac mortality, 
remained significant in multivariable analysis (Table 2).  
 
Mortality and cardiac events 
Twelve studies reported on the combined endpoint. Cardiac mortality was chosen as 
endpoint in case the study reported on more than one endpoint. The pooled OR for all-
cause and cardiac mortality and cardiac events in 1649 anxious compared with 4101 
non-anxious MI patients was 1.36 (95% CI: 1.18-1.56; p<.001) in the FEM (Figure 
2). No heterogeneity was observed in the model (I²=0.00%) and therefore no 
difference in the OR given by the FEM and REM.  
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The pooled OR for all-cause mortality in 925 anxious compared with 2241 non-
anxious MI patients was 1.47 (95% CI: 1.02-2.13; p=.04) in the FEM and 1.53 (95% 
CI: 0.95-2.46; p=.08) in the REM. For cardiac mortality, the pooled OR comparing 
265 anxious with 1072 non-anxious MI patients was 1.23 (95% CI: 1.03-1.47; p=.02) 
in the FEM and 1.33 (95% CI: 0.89-1.98; p=.16) in the REM.  
Although the included events varied across studies, all studies reporting on cardiac 
events included cardiac death and recurrent MI as endpoint. The pooled OR for 
cardiac events in 579 anxious compared with 1075 non-anxious MI patients was 1.71 
(95% CI: 1.31-2.23; p<.001) in the FEM and REM. 
 
The influence of anxiety on prognosis varied between endpoints. The impact of 
anxiety was significantly larger for cardiac events than for cardiac mortality (p=.04). 
The impact of anxiety on cardiac events was not significantly different from the 
impact on all-cause mortality (p=.52). 
 
Because the 12 studies reporting on the combined endpoint did not show significant 
heterogeneity, no further secondary analyses were conducted.  
 
A funnel plot of selected studies on the combined outcome suggests the presence of 
publication bias (Figure 4). Further inspection of the studies divided by endpoint 
revealed a possible bias for all-cause and cardiac mortality, but not for cardiac events 
(not shown).  
 
Discussion 
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This is the first meta-analysis focusing on the association of anxiety with prognosis in 
heart disease patients. The results show a consistent association between anxiety and 
impaired prognosis after MI, with a 36% increased risk. This increased risk applies to 
both mortality (cardiac and all-cause) and cardiac events. Although the association 
between anxiety and cardiac events was significantly larger compared with that of 
cardiac death, these results should be interpreted with caution because the pooled OR 
for cardiac death was based on only 4 studies. Overall, these findings support the 
conclusion that anxiety is associated with adverse medical outcomes after MI. 
 
 In this meta-analysis, only one study reported on anxiety disorder, namely 
generalized anxiety disorder (GAD) [20]. In bivariate analysis, both self-reported 
symptoms and GAD were predictors of cardiac events. In multivariable analysis, only 
the association between GAD and prognosis remained significant. To date there is 
little information about the association between different anxiety disorders and 
cardiac outcome. Clearly, further research on the relationship between anxiety 
disorders and prognosis is warranted. 
  
There are several potential mechanisms that may help to explain the adverse 
association between anxiety and cardiac prognosis. Anxiety is potentially related to 
several pathophysiological processes in MI patients, including arrhythmic 
mechanisms [42] and dysfunction of the autonomic nervous system, such as reduced 
baroflex cardiac control [43] and reduced heart rate variability [44]. Theoretically, it 
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may be that anxiety has a more influential role in electrical instability rather than in 
atherosclerotic or vascular disease conditions. In two studies cardiac arrest was 
included as endpoint [18,31]. One study found a significant association between 
anxiety and cardiac events (including survived cardiac arrest) [18] and the other found 
no association between anxiety and all-cause mortality or cardiac arrest in patients at 
risk of sudden death [31]. However, both studies did not assess the association 
between anxiety and cardiac arrest specifically. More research is needed to the 
association of anxiety with arrhythmic mechanisms. 
In addition, a behavioral pathway of depression influencing prognosis is unhealthy 
behavior, like less compliance, smoking, unhealthy diet and inactivity [5]. This may 
also hold for anxious patients. Reversely, it is possible that anxious patients seek more 
help from their doctors and try to improve their medical status [11]. However, 
Benninghoven et al. found that patients with higher anxiety levels showed neither 
better medication compliance nor had more contact with their cardiologists [11]. 
Given that some studies have found a protective effect of anxiety on outcome [25] it 
might be that it is anxiety in combination with nonprotective patient behavior that 
leads to worse prognosis, possibly due to an avoidant coping strategy [11] or social 
inhibition [45]. Further research regarding the behavioral and pathophysiological 
mechanisms responsible for the relationship between anxiety and prognosis is 
warranted. 
 
The prognostic association between anxiety and prognosis after MI seems smaller 
than that of depression [5], but larger as compared to the effects of anger and hostility. 
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A recent meta-analysis showed that anger and hostility were associated with a 24% 
increased risk of poor prognosis in CHD patients [46]. Overall, these results show that 
various psychological factors, of which depression is probably the most important 
one, are consistently associated with adverse outcome in heart disease patients.  
 
It is important to assess the extent to which the association between anxiety and 
prognosis is independent of other clinical and psychological variables, such as 
depression. Studies have found rather mixed results, with some studies retaining 
depression [27] and others anxiety [15,26]. In addition, anxiety and depression have a 
moderate to strong correlation [47], yet anxiety and depression also have distinctive 
features [47]. It is possible that anxiety and depression are both part of a larger and 
more stable factor influencing prognosis in heart disease patients, like negative 
affectivity [47] or Type D personality (a combination of negative affectivity and 
social inhibition) [45].  
Somatic symptoms of depression such as fatigue are known to be related to disease 
severity [48]. In a meta-analysis on the association between depression and CHD 
prognosis, adjustment for left ventricular function reduced the relative risk with 
almost 50% [49]. On the contrary, disease severity adjusted ORs of the association 
between anxiety and medical prognosis after MI are only slightly or not attenuated 
[18,26,27]. This could indicate that the association between anxiety and medical 
outcome is less confounded by disease severity as compared to depression. 
 
Results of this meta-analysis indicate that treatment of distressed MI patients should 
not focus on depression exclusively. Large intervention trials have failed to improve 
medical prognosis in depressed MI patients [50-51], perhaps because related anxiety 
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was not treated [47]. There is a need for more behavioral medicine programs 
performing clinical outcomes research [52], in which various risk factors (e.g. 
depression, anxiety and hostility/anger) should be targeted.  
 
The results need to be considered in light of the study limitations. One of the most 
important limitations in conducting a meta-analysis is the inevitability of combining 
data from studies that are not equally designed. Patient samples were heterogeneous 
regarding gender and disease severity, and follow-up duration differed substantially 
across studies. However, the results of the included studies were quite homogeneous 
and it therefore seems that the finding of a significant prospective association between 
anxiety and CHD prognosis is robust.  
 
Anxiety is a very heterogeneous emotion and individuals may experience different 
kinds of anxiety symptoms. In order to limit heterogeneity we excluded studies on 
phobia and post traumatic stress disorder. Still, it remains unclear which aspects of 
anxiety contribute to cardiac outcomes. Further, 6 studies measured anxiety using the 
STAI. Research has shown that the STAI does not clearly differentiate anxiety from 
depression [53]. There is a need for more research to the construct of anxiety, its core 
features and development of new instruments. An additional limitation is the lack of 
temporal information about onset of anxiety. We do not know if included patients 
became anxious as a result of their MI or were already anxious prior to developing 
CHD. Although studies suggest an association between anxiety and heart disease in 
initially healthy persons as well [8], more research should focus on this topic and the 
possible differences between these groups. Another limitation is that two studies had 
to be excluded because of insufficient data. Of these studies, one reported a 
significant [37] and one reported a non-significant [38] effect of anxiety on outcome. 
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Another limitation concerns the proneness of meta-analyses to publication bias. We 
tried to minimize important sources of publication bias by including both non-English 
and nonpublished work in our literature search. We found a possible publication bias 
for mortality suggesting that the association between anxiety and mortality might be 
smaller than reported here. However, for the largest association found in this meta-
analysis, namely between anxiety and cardiac events, we did not find indications of 
publication bias. 
Since the existing literature is quite small and contains several limitations, there is a 
need for further research to the association of anxiety and cardiac prognosis in MI 
patients. In the future, when more studies are published on this subject, this meta-
analysis should be brought up to date.  
In summary, post-MI anxiety is consistently related to adverse cardiac events in 
bivariate analyses. Findings are homogeneous and reliable, although more research is 
needed to assess the extent to which this association is independent of other 
psychological and clinical variables. The association between anxiety and outcome 
seems less strong than it is for depression, however, it might be less confounded by 
disease severity. The results from this study indicate the need for future research 
directed to the association between anxiety and prognosis after MI, to the 
identification of the underlying processes by which anxiety contributes to cardiac 
prognosis and to the testing of interventions to alleviate the associated risk. 
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Table 1. Overview of selected studies investigating the association of anxiety with prognosis in post-MI patients 
 




Instrument Anxiety assessment  




















MI 347 63 73 HADS-A ≤3 18.5  0 All-cause mortality 1.5 State 1994  No 
Carinci (9) 
 
MI 2449 NA 88 CBAHF 
Anxiety 
subscale  
≤3 30.1 0 All-cause mortality 0.5 State 1989 No 
Denollet (40) MI 105 54 
 
100 STAI 21-42 49.5 0 Cardiac + all-cause mortality 3.8 Trait 1986 No 
Lane (22) 
 
MI 288 63 75 STAI 2-15  26.1 0 Cardiac + all-cause mortality 3.0 State  1997  No 
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Benninghoven (11) MI 76 NA 
 
80 STAI <7 30.3 0 Cardiac events** 2.6 State  1999  No 
Michael (30) First MI/UA  65 60 46 
 
HADS-A During hospital admission 26.2 0 Cardiac ischemic events  0.5 State NA No 
Frasure-Smith (18) MI/UA 804 60 81 HADS-A 2 months after discharge 41.4 <1.0 Cardiac events*** 2.0 State 1999 Yes 
 































             
 
MI=myocardial infarction; HADS-A=Hospital Anxiety and Depression Scale –Anxiety subscale; NA=not available; UA=unstable angina; CBAHF=Cognitive Behavioral Assessment Hospital Form; STAI=State Trait 
Anxiety Inventory; SCL=Symptom Check List; STPI=State Trait Personality Inventory. 
  
¹         Global left ventricular ejection fraction (LVEF) ≤50%  
²         Patients at risk for sudden death (≥10 ventricular premature complexes/hour or ≥5 episodes of nonsustained ventricular tachycardia) 
*        Cardiac death or recurrent MI 
**      Cardiac death, MI or revascularization 
***    Cardiac death, MI, survived cardiac arrest, nonelective revascularization 
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Table 2. Overview of positive studies in which the influence of anxiety on endpoints was adjusted for other variables 
 





Frasure-Smith (27) Cardiac mortality 1.21 (1.01-1.46) 1.14 (0.93-1.38) Age, gender, educational level, daily smoking, previous MI, thrombolytic treatment at index admission, Q-
wave MI, Killip class >1, revascularization at index admission, LVEF, antidiabetic medication and β-
blockers. 
 
Denollet (41) Cardiac mortality 3.70 (1.10-12.40) 4.66 (1.20-18.17)*# LVEF≤30% 
 
Denollet (41) Cardiac events 3.40 (1.20-9.60) 3.69 (1.27-10.70)*# LVEF≤30% 
 







Cardiac events 1.67 (1.18-2.37) 1.45 (0.95-2.22) Age, gender, education, current daily smoker, previous MI, CABG or angioplasty, LVEF <45%, CABG 
during index hospitalization, ≥ 1 coronary vessel with ≥ 50% blockage after index revascularization, BMI, 
fasting triglyceride level, diastolic blood pressure, calcium channel blockers, angiotensin-converting enzyme 
inhibitors, and statins. 
 
LVEF=left ventricular ejection fraction; MI=myocardial infarction; CABG=coronary artery bypass graft; BMI=body mass index,  
 
* OR provided by Denollet 
**  Based on own calculations 
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studies based on 
full text 
N= 23
Analyses reporting on 
anxiety related all- 
cause mortality
N=4
Analyses reporting on 
anxiety related cardiac 
mortality
N=4
Analyses reporting on 










1. Patients not hospitalized for MI n= 2      
2. No reliable anxiety measure or
    not measured before 3 months n= 4
3. No endpoints containing
    mortality or MI or no prognostic 
    relationship between anxiety 
    and endpoints n= 5
4. Authors unable to give necessary 
    data n= 2
After exluding 
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Figure 3. Funnel plot of selected studies 
 
 
Heterogeneity I²=0.00% 
